Press

World Journal of Men’s Health Article
Men’s Health Magazine
Urology Times

Studies

Therapeutic Advances in Urology
Can Low-Intensity Extracorporeal Shockwave Therapy Improve Erectile Function? A 6-Month Follow-up Pilot Study in Patients with Organic Erectile Dysfunction
Penile Low­Intensity Shock Wave Therapy: A Promising Novel Modality for Erectile Dysfunction
extracorporeal shock wave therapy have a physiological effect on erectile function? Short­term results of a randomized, double- blind, sham controlled study.
Low­intensity extracorporeal shock wave therapy­­a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy.
Can low-intensity extracorporeal shockwave therapy improve erectile dysfunction? A prospective, randomized, double-blind, placebo- controlled study
Low intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population.
Low intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population.
Low intensity extracoporeal shockwave therapy for erectile dysfunction: a study in an Indian Population
European Urology Erectile Dysfunction
Shockwave treatment of erectile dysfunction
Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’s disease and erectile dysfunction: results from a prospective randomized trial
Effi ciency Assessment of Shock Wave Therapy in Patients with Pelvic Pain Employing Harmonic Analysis of Penile Bioimpedance
Twelve-Month Efficacy and Safety of Low-Intensity Shockwave Therapy for Erectile Dysfunction in Patients Who Do Not Respond to Phosphodiesterase Type 5 Inhibitors
Twelve-Month Efficacy and Safety of Low-Intensity Shockwave Therapy for Erectile Dysfunction in Patients Who Do Not Respond to Phosphodiesterase Type 5 Inhibitors
Peyronie’s disease and low intensity shock wave therapy: Clinical outcomes and patient satisfaction rate in an open-label single arm prospective study in Australian men
Peyronie’s diseaseÐthe Plymouth experience of extracorporeal shockwave treatment
Safety and efficacy of low intensity shockwave (LISW) treatment in patients with erectile dysfunction
Extracorporeal shockwave therapy in the treatment of erectile dysfunction: A prospective, randomized, double-blinded, placebo controlled study
Treatment of Peyronie’s Disease by Extracorporeal Shockwave Therapy: Evaluation of Our Preliminary Results
Penile Low-Intensity Shock Wave Therapy: A Promising Novel Modality for Erectile Dysfunction
Shockwave Therapy as First-Line Treatment for Peyronie’s Disease: A Prospective Study
Low-Intensity Extracorporeal Shock Wave Therapy—A Novel Effective Treatment for Erectile Dysfunction in Severe ED Patients Who Respond Poorly to PDE5 Inhibitor Therapyjsm_2498
Penile Low Intensity Shock Wave Treatment is Able to Shift PDE5i Nonresponders to Responders: A Double-Blind, Sham Controlled Study
Does Low Intensity Extracorporeal Shock Wave Therapy Have a Physiological Effect on Erectile Function? Short-Term Results of a Randomized, Double-Blind, Sham Controlled Study
Therapeutic advances in the treatment of Peyronie’s disease
Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial
Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’s disease and erectile dysfunction: results from a prospective randomized trial
Initial experience with linear focused shockwave treatment for erectile dysfunction: a 6-month follow-up pilot study
Impact of aging and comorbidity on the efficacy of low-intensity shock wave therapy for erectile dysfunction